Please ensure Javascript is enabled for purposes of website accessibility

Here's Why JPMorgan Chase and Other Bank Stocks Are Up on Friday

By Matthew Frankel, CFP® – Apr 17, 2020 at 11:46AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite an otherwise ugly week, the big banks were one of the best-performing parts of the market today.

What happened

The stock market had an extremely strong opening on Friday, but the rally had started to lose steam by late morning. At 11 a.m. EDT today, the Dow Jones Industrial Average and S&P 500 index were both higher by about 1.6%.

Bank stocks reported first-quarter results this week and had been one of the worst-performing sectors in the market, but are reversing course somewhat today. All of the big banks are handily outperforming the overall stock market. Citigroup (C -1.78%) is the top performer of the megabanks, up nearly 7% for the day. JPMorgan Chase (JPM -2.04%) is up by about 6%, and Wells Fargo (WFC -2.47%) is higher by more than 4%.

Man with fist in the air in celebration.

Investors are cheering the latest developments in the fight against the coronavirus pandemic. Image source: Getty Images.

So what

First, keep in mind that the bank stocks have been awful performers this week. Through Thursday, these banks had declined by 14% to 19% this week alone. So, keep today's performance in perspective: The banks are still significantly lower than they were at this time a week ago.

The reason for the recent poor performance is that all of the big banks revealed that they set aside billions in additional loan loss reserves in the first quarter, indicating that they're anticipating a wave of defaults throughout the COVID-19 pandemic.

Well, there were a couple of good news items last night that are encouraging signs the economic shutdown might not last as long as feared. First, we learned that Gilead Sciences' (GILD -0.76%) antiviral medication remdesivir is showing signs of effectiveness at treating severe cases of COVID-19. A truly effective treatment against the virus could be a game changer, and while it's certainly too early to call the drug a success (these are just initial results, not a complete trial), this is a promising development.

Second, we're starting to see a clear light at the end of the tunnel in terms of reopening the economy. Some states are starting to give set dates when lockdowns will be relaxed, and the president just released a three-stage plan for reopening the economy as coronavirus cases start to decline.

The point is that if the economy reopens sooner rather than later, it could mean that loan defaults aren't going to get as bad as the banks' reserve builds are suggesting. Think of it this way: Average U.S. consumers are less likely to fall behind on their monthly debt obligations if they can get back to work in May rather than June or July. And that seems to be the hope reflected in the stock market today.

Now what

To be clear, we're a long way from being out of the woods. People are still getting sick and dying from the coronavirus at an alarming rate, and the peak isn't expected in many parts of the U.S. for several weeks. But any news that shows the end is in sight is likely to be perceived as a positive sign by investors, and since the banking industry is highly sensitive to recessions, we're seeing that reflected in bank stocks today.

Matthew Frankel, CFP has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Gilead Sciences. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Citigroup Inc. Stock Quote
Citigroup Inc.
$43.06 (-1.78%) $0.78
JPMorgan Chase & Co. Stock Quote
JPMorgan Chase & Co.
$108.14 (-2.04%) $-2.25
Wells Fargo & Company Stock Quote
Wells Fargo & Company
$42.24 (-2.47%) $-1.07
Gilead Sciences Stock Quote
Gilead Sciences
$64.95 (-0.76%) $0.50

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.